U.S. Industrial REITs Stock News

Teradyne (TER) shares have been quietly making moves this month, catching some investors off guard. There was no headline-grabbing event to set things in motion, but the stock's recent surge of nearly 17% over the past month is hard to ignore. This kind of swing, absent a big announcement, often gets investors thinking: is something quietly shifting under the hood, or is the market simply readjusting its view on what Teradyne is worth after a stretch of sluggish performance? Looking at the...

Thinking about what to do with Broadridge Financial Solutions stock right now? You are not alone. With so many investors buzzing about where the market is headed, Broadridge has been quietly putting in the work, and its share price stories reflect that determination. Whether you are a cautious buyer or someone looking for growth upside, there is a lot here to consider. Broadridge’s recent price action makes it tough to ignore. The stock is up more than 14% year-to-date, and long-term...

If you find yourself pondering what to do with Kraft Heinz stock right now, you are not alone. Investors have watched the company’s share price swing between ups and downs over the past year, with a recent close at $27.50. While it might look like another sleepy packaged foods company at first glance, Kraft Heinz has quietly been stirring up some headlines and shifting sentiment in the market. In the past month, shares have dipped about 4.4%, and for the year they are down over 10%. But zoom...

If you are trying to figure out what to do with QUALCOMM right now, you are not alone. With so much news swirling around the semiconductor industry, QUALCOMM's recent price swings have caught more than a few eyes. Over the last year, QUALCOMM's shares have dipped about 6.8%, but over the past five years, the stock is up by almost 48%. This fluctuation has investors wondering whether it's time to get involved, stay put, or wait it out. Some of this turbulence comes down to shifting headlines,...

LegalZoom.com, Inc. recently expanded its intellectual property legal services, introducing attorney-assisted provisional patent application services through LZ Legal Services to offer more affordable and accessible patent filing options for businesses and inventors in the US. This move leverages LegalZoom's technology-enabled platform to streamline patent protection, potentially reaching inventors and startups priced out by traditional legal services. We'll explore how LegalZoom's entry...

If you have been watching Johnson & Johnson (JNJ) shares recently, the steady upswing in its price may have caught your attention. While there has not been a specific news event driving the stock this week, the movement could be making investors pause and wonder if a turning point is underway. When a household name like Johnson & Johnson starts building momentum, it is natural to ask if the market is catching onto something or if this is just a routine stretch higher. Zooming out, Johnson &...

Earlier this week, Arm Holdings announced it has hired Rami Sinno, former AI chip director at Amazon and key architect behind Amazon’s Trainium and Inferentia processors, to lead its push into designing complete AI chips and systems. This move marks a major shift for Arm, signaling its intent to move beyond core design licensing to directly building its own chips and more fully compete in the AI semiconductor market. We'll explore how Arm's recruitment of recognized AI chip expertise could...

In the past week, Snappt, Hackensack Meridian Health, Tampa General Hospital, and Nordic all announced new partnerships with CLEAR, while CLEAR extended its CLEAR+ service to travelers from the UK, Canada, Australia, and New Zealand in the U.S. airport market. The rapid series of integrations and international expansions highlights a sharp acceleration in real-world adoption of CLEAR's biometric identity platform across healthcare, property management, and global travel. We’ll explore how...

Wondering whether Wolfspeed stock deserves a fresh look, or if it's best left on the sidelines? You are not alone. Investors have been scratching their heads over steep swings in share price, especially given how sharply sentiment has shifted. Over just the past year, the stock has tumbled nearly 90%, even though revenue has grown by a double-digit percentage and net income has improved at an impressive rate. It's a classic case of the market grappling with big promises for the future set...

Thinking about what to do with GE Vernova stock these days? You are not alone. Whether you are considering taking profits after a banner run or nervous about missing out, this stock has grabbed plenty of investor attention lately. After a whopping 79% year-to-date surge, a steady climb of over 30% in the past three months, and a new life at over $600 per share, GE Vernova’s momentum speaks for itself. Investors betting on the clean energy transition and infrastructure upgrades have helped...

Deciding what to do with RTX stock right now? You are not alone. This American industrial heavyweight has captured plenty of investor attention in 2024, bouncing back with an impressive 34.7% gain year-to-date. In fact, over the past year, RTX has notched a total return of 35.1%. The stock has steadily climbed out of last year’s uncertainty, in part due to rebounding defense contracts and a brightening outlook in the aerospace sector. Market sentiment seems to have shifted as well. Recent...

If you have been keeping an eye on Electronic Arts stock lately, you are probably wondering if now is the right time to jump in, cash out, or just sit tight. EA's share price has delivered some excitement over the past year, with a solid 17% total return, and a strong showing in the past quarter, climbing nearly 17%. That is the kind of run that grabs attention. It is tempting to assume the best days are yet to come, especially when big-name franchises and major market trends are in play. But...

On August 14, 2025, Celcuity Inc. announced its results for the second quarter and first half of 2025, reporting a net loss of US$45.27 million for the quarter and US$82.27 million for the six-month period, both wider than the prior year. The company's loss per share also increased compared to last year, highlighting heightened operating expenses and a growing financial gap. We'll explore how the deepening net losses shape Celcuity's investment narrative and what they signal about its...

MetLife (MET) has popped up on investors’ radars again, thanks to its recent run in the stock price. While there has not been a headline-grabbing event or major announcement, the steady climb in the share price has naturally raised some eyebrows among those weighing their next move. For investors tuned into the insurance sector, these kinds of slow-burn rallies can be just as interesting as splashy news. Sometimes, they are even more telling when it comes to forecasting value. Looking at the...

If you are eyeing Republic Services right now, you are certainly not alone. As one of the biggest names in the waste management game, RSG has been quietly churning out steady gains, attracting both growth seekers and investors who want some defensive stability in their portfolio. But the question a lot of us keep circling back to is, at these levels, is the stock actually undervalued or has all the upside been priced in? Recent stock price action gives us plenty to discuss. Over the last...

If you have been watching Lam Research lately, you know it has been quite a ride. Whether you are an investor on the fence or simply curious about this semiconductor powerhouse, there is no denying how dynamic things have become with LRCX. Over the past three months, shares have surged more than 21% as investors have warmed to the chip sector again and shrugged off broader market jitters. Year-to-date, Lam is up a robust 36%, adding to already impressive long-term gains. What is driving this...

If you are tracking Adaptive Biotechnologies (ADPT), the news that its strategic collaboration and license agreement with Genentech will be winding down might catch your attention. The deal, first signed in 2018 to jointly explore innovative cancer cell therapies, is set to terminate in early 2026. This will free Adaptive from previous exclusivity constraints in oncology. Notably, this change will unlock a $33.7 million boost in non-cash revenue later this year, adding detail to the...

Earlier this month, Coastal Financial Corporation and its subsidiary, Coastal Community Bank, announced the appointment of four new executives to its leadership team, introducing key talent in product, commercial, credit, and information security roles. This leadership expansion signals a commitment to strengthening the company's digital banking capabilities and advancing its risk management practices amid ongoing growth initiatives. We'll explore how the addition of experts with fintech and...

Earlier this week, JPMorgan upgraded Hormel Foods based on an anticipated increase in demand for the company's protein-focused and cleaner-label products, despite recent softness in sales volumes and profitability challenges. This analyst action stands out because it contrasts with the company's recent struggle to maintain higher sales and profit margins in a competitive market. We'll explore how JPMorgan's optimism around demand for Hormel's protein and natural ingredient offerings could...

If you have been watching Quest Diagnostics (DGX) lately, the recent dip in its stock price might have raised an eyebrow or two. Shares edged down about 0.4% after a period of impressive year-to-date growth. While there is no headline-grabbing event behind this move, subtle shifts like this often prompt investors to step back and re-evaluate what the market may be signaling about future prospects. Looking at the bigger picture, Quest Diagnostics has quietly outperformed many of its peers...

If you are trying to decide what to do with Stryker stock right now, you are not alone. The company’s shares have had a busy year, climbing more than 10% over the past 12 months and sitting up over 72% year to date. That is impressive, especially considering a recent dip over the past month and an overall return of more than 100% over five years. Stryker’s ability to consistently generate revenue growth and boost its bottom line has kept investors interested, even while the broader healthcare...

Procter & Gamble (PG) has turned heads after a quiet drift downward this year, with shares now sitting just below where they started twelve months ago. It is not a major announcement or earnings miss that is catching investors’ attention; rather, the subtle slide has left some wondering if the world’s biggest household products maker is setting up for a comeback or bracing for more caution from the market. On the surface, it has been an unexciting year for Procter & Gamble. The stock edged...

Thinking about what to do with Fortinet stock? You are not alone in wondering whether now might be the right time to buy, hold, or steer clear. After all, the cybersecurity giant has had a rollercoaster year in the market, which has probably left many investors feeling a bit whiplashed. Over the past three months, shares have pulled back by about 25%. If you zoom out to three or even five years, the returns are nothing short of impressive: up more than 52% and 194% respectively. Even with...

If you are contemplating what your next move should be with DuPont de Nemours stock, you are definitely not alone. Investors have been trying to make sense of its latest performance, wondering whether recent ups and downs hint at a hidden bargain or newly introduced risks. Over the past three months, DuPont shares have rebounded by more than 10%, outpacing the broader market as investors responded to improved sentiment about the company’s prospects and shifting macroeconomic conditions. Even...